AU2004229317B2 - Assessing neuronal damage from blood samples - Google Patents

Assessing neuronal damage from blood samples Download PDF

Info

Publication number
AU2004229317B2
AU2004229317B2 AU2004229317A AU2004229317A AU2004229317B2 AU 2004229317 B2 AU2004229317 B2 AU 2004229317B2 AU 2004229317 A AU2004229317 A AU 2004229317A AU 2004229317 A AU2004229317 A AU 2004229317A AU 2004229317 B2 AU2004229317 B2 AU 2004229317B2
Authority
AU
Australia
Prior art keywords
injury
blood
antibody
detecting
neuronal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004229317A
Other languages
English (en)
Other versions
AU2004229317A1 (en
Inventor
Brian R. Pike
Gerry Shaw
Sonal S. Tuli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Publication of AU2004229317A1 publication Critical patent/AU2004229317A1/en
Assigned to UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. reassignment UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. Request for Assignment Assignors: UNIVERSITY OF FLORIDA
Application granted granted Critical
Publication of AU2004229317B2 publication Critical patent/AU2004229317B2/en
Priority to AU2012202051A priority Critical patent/AU2012202051A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU2004229317A 2003-03-31 2004-03-26 Assessing neuronal damage from blood samples Ceased AU2004229317B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012202051A AU2012202051A1 (en) 2003-03-31 2012-04-11 Assessing neuronal damage from blood samples

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45928603P 2003-03-31 2003-03-31
US60/459,286 2003-03-31
PCT/US2004/009114 WO2004091379A2 (en) 2003-03-31 2004-03-26 Assessing neuronal damage from blood samples

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012202051A Division AU2012202051A1 (en) 2003-03-31 2012-04-11 Assessing neuronal damage from blood samples

Publications (2)

Publication Number Publication Date
AU2004229317A1 AU2004229317A1 (en) 2004-10-28
AU2004229317B2 true AU2004229317B2 (en) 2012-01-12

Family

ID=33299668

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004229317A Ceased AU2004229317B2 (en) 2003-03-31 2004-03-26 Assessing neuronal damage from blood samples

Country Status (10)

Country Link
US (3) US20040241762A1 (enExample)
EP (1) EP1613204B1 (enExample)
JP (1) JP4557971B2 (enExample)
AT (1) ATE440286T1 (enExample)
AU (1) AU2004229317B2 (enExample)
CA (1) CA2520945C (enExample)
DE (1) DE602004022645D1 (enExample)
DK (1) DK1613204T3 (enExample)
ES (1) ES2332136T3 (enExample)
WO (1) WO2004091379A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005113798A2 (en) * 2004-04-15 2005-12-01 University Of Florida Research Foundation, Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
WO2007139866A2 (en) * 2006-05-24 2007-12-06 The University Of Miami Screening method and system to estimate the severity of injury in critically ill patients
US20100159615A1 (en) * 2006-12-27 2010-06-24 Haruo Matsuda Immunological detection method using avian antibody
US20140038834A1 (en) * 2010-07-07 2014-02-06 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Novel biomarkers for detecting neuronal loss
CA2943396A1 (en) * 2014-04-07 2015-10-15 Iron Horse Diagnostics, Inc. Traumatic brain injury and neurodegenerative biomarkers, methods, and systems
KR102893528B1 (ko) * 2018-07-27 2025-11-28 베라바스, 인크. 고갈 및 농축을 위한 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86652A1 (de) * 1986-11-10 1988-06-13 Progen Biotechnik Gmbh Verfahren zum auffinden von gewebslaesionen
EP0378924B1 (en) * 1988-12-21 1996-11-13 The General Hospital Corporation Detection of neurological disease or dysfunction
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
GB9719879D0 (en) * 1997-09-19 1997-11-19 Neuropa Ltd Protein
US6589746B1 (en) * 1999-10-21 2003-07-08 University Of Cincinnati Method of detecting axonally-derived protein tau in patients with traumatic CNS injury

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HASHIMOTO, R. et al., Psychiatry and Clinical Neurosciences, 1999, Vol. 53, pages 587-591 *
HU Y-Y et al., NEUROSCIENCE LETTERS, 2002, Vol. 320, pages 156-160 *
NYLEN, K. et al., Journal of Neuroscience Research, 2002, Vol. 67, pages 844-851 *
POSMANTUR, R. et al., Journal of Neurotrauma, 1994, Vol. 11, No. 5, pages 533-545 *
SKOUEN, J. S. et al., Spine, 1999, Vol. 24, No. 21, pages 2195-2200 *

Also Published As

Publication number Publication date
WO2004091379A2 (en) 2004-10-28
WO2004091379A3 (en) 2005-12-22
EP1613204A2 (en) 2006-01-11
US20100184105A1 (en) 2010-07-22
HK1085538A1 (en) 2006-08-25
JP4557971B2 (ja) 2010-10-06
EP1613204B1 (en) 2009-08-19
JP2006522336A (ja) 2006-09-28
CA2520945A1 (en) 2004-10-28
ATE440286T1 (de) 2009-09-15
EP1613204A4 (en) 2007-04-04
AU2004229317A1 (en) 2004-10-28
DK1613204T3 (da) 2009-12-07
US20040241762A1 (en) 2004-12-02
DE602004022645D1 (de) 2009-10-01
US20160349272A1 (en) 2016-12-01
ES2332136T3 (es) 2010-01-27
CA2520945C (en) 2014-03-25

Similar Documents

Publication Publication Date Title
CA2607285C (en) Diagnosis of liver pathology through assessment of protein glycosylation
US20160349272A1 (en) Assessing neuronal damage from blood samples
JP5963900B2 (ja) オートタキシン測定による悪性リンパ腫の検査方法および検査薬
JPH06502912A (ja) アナライト変異体分析
JP7449530B2 (ja) 腎癌の検出方法及び検査薬
JP5090332B2 (ja) 炎症及び感染症のためのバイオマーカーとしての短鎖ｓｒｌアルコールデヒドロゲナーゼ（ｄｈｒｓ４）の測定
JP7709703B2 (ja) 膵臓がんの検出方法及び検出試薬
HK1085538B (en) Assessing neuronal damage from blood samples
AU2012202051A1 (en) Assessing neuronal damage from blood samples
JPH07309895A (ja) 新規タンパク質、その検出方法及び診断薬
JP7818217B2 (ja) 呼吸器感染症の重篤度判別方法および試薬
WO2025182761A1 (ja) Ｇｆａｐの検出方法、アルツハイマー病の診断を補助する方法、及びそれらに用いるキット
US20230053846A1 (en) Method for detecting cancer bone metastasis and detection reagent
AU2015275300B2 (en) Diagnosis of liver pathology through assessment of protein glycosylation
AU2012247075B2 (en) Diagnosis of liver pathology through assessment of protein glycosylation
HK1228005A1 (en) Diagnosis of liver pathology through assessment of fucosylated kininogen

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.

Free format text: FORMER APPLICANT(S): UNIVERSITY OF FLORIDA

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired